CTD / eCTD modules, variation packages and FSA / EFSA novel-food applications, all backed by analytical evidence from our own laboratory. We write the story the regulator needs and we own the data behind it.
eCTD Module 3 (Quality) authoring and CMC support
Variation packages (Type IA, IB, II) — analytical evidence and writing
FSA novel-food applications (UK)
EFSA novel-food applications (EU)
Health-claim and nutrition-claim dossiers
Specifications drafting for new ingredients and finished products
Stability programme design for submission support
Pre-submission gap analysis and regulator-readiness review
3.2.S (Drug Substance), 3.2.P (Drug Product) sections and quality overall summaries.
Section-by-section authoring per FSA / EFSA guidance.
ICH Q6A-aligned specifications with justification.
ICH Q14 and Q2(R2) consideration for analytical sections.
ICH Q1A / Q1E-aligned design and shelf-life justification.
Documented pre-submission assessment with closure plan.
Methods, documentation and acceptance criteria are designed to align with the standards below. This describes design intent — formal accreditations are listed on the About page.
eCTD-ready Module 3 sections
Variation application packages
FSA / EFSA novel-food dossiers with safety dataset
Health-claim substantiation packages
Pre-submission gap analysis with closure plan
Regulator-response support packages
Send a short scope and we'll come back with a quote and indicative timeline within one working day.